Switzerland startup funding in H2 2026
European tech funding raised by Switzerland startups during H2 2026.
H2 2026 is in progress (through 2026-11-22): 84 startups in Switzerland have closed 84 funding rounds and raised €742M in equity funding so far (excluding debt and grants). Debt rounds added €63M. Healthtech is the most active sector, and Venture Kick is the most active investor. Data as of 20 Nov 2026.
H2 2026 is in progress — these figures cover rounds through today and will grow as the period completes, so they are not compared to H2 2025.
Equity funding
€742M
excl. debt & grants · +€63M debt
Funding rounds
84
Companies
84
Top sector
Healthtech
Rank in Europe
#8
1.8% of European funding
Debt financing
€63M
7.8% of total
Top-10 round share
78.3%
of disclosed capital
Rounds ≥ €100M
2
Funding by month
€ raised vs rounds, by monthSwitzerland — funding by month, H2 2026 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Jul | €224M | 23 |
| Aug | €217M | 9 |
| Sep | €62M | 23 |
| Oct | €292M | 20 |
| Nov | €14M | 9 |
Top sectors
by € raisedSwitzerland — top sectors by capital, H2 2026 — interactive chart.
Data table
| Switzerland — top sectors by capital, H2 2026 | |
|---|---|
| Healthtech | €313M |
| Robotics | €204M |
| Deeptech | €101M |
| Semiconductors | €61M |
| Software | €41M |
| AI | €38M |
| Cleantech | €19M |
| Fintech | €6.7M |
Stage mix
by € raisedSwitzerland — stage mix, H2 2026 — interactive chart.
Data table
| Switzerland — stage mix, H2 2026 | |
|---|---|
| Series A | €226M |
| Series B | €200M |
| Other | €148M |
| Seed | €66M |
| Debt | €63M |
| Series C | €61M |
| Pre-Seed | €41M |
| Grant | €3.2M |
Exits & M&A
11 Acquisition11 exits.
Top deals
largest disclosed rounds in H2 2026| Company | Stage | Date | Amount |
|---|---|---|---|
| Gravis Robotics | Series A | Aug 2026 | €173M |
| Nouscom | Series B | Oct 2026 | €120M |
| CCRAFT | Other | Jul 2026 | €68M |
| DistalMotion | Debt | Oct 2026 | €63M |
| Swissto12 | Series C | Jul 2026 | €61M |
| Namespace | Series B | Oct 2026 | €37M |
| Adaptyv Biosystems | Series A | Aug 2026 | €34M |
| Enact Intelligence | Pre-Seed | Oct 2026 | €27M |
| NovaGo Therapeutics | Series B | Sep 2026 | €26M |
| ZuriQ | Seed | Jul 2026 | €22M |
| Xeltis | Other | Jul 2026 | €19M |
| Hilo (Aktiia) | Series B | Jul 2026 | €17M |
| AI Infrastructure Capital | Other | Jul 2026 | €16M |
| ETFbook | Other | Sep 2026 | €11M |
| Atlas Bio | Seed | Oct 2026 | €11M |
Top investors
most active in H2 2026, by deal count- Venture Kick15 deals
- Zürcher Kantonalbank5 deals
- new investors4 deals
- KickFund3 deals
- Founderful3 deals
- Playfair Capital3 deals
- CDP Venture Capital2 deals
- EQT Life Sciences2 deals
- SICTIC2 deals
- Family Offices2 deals